{"id":"W1979235170","doi":"10.7448/ias.15.6.18112","title":"Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor‐based regimen: week 24 phase 3 results from VIKING‐3","year":2012,"lang":"en","type":"article","venue":"Journal of the International AIDS Society","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Regimen; Medicine; Integrase inhibitor; Resistance mutation; Population; Viral load; Internal medicine; Gastroenterology; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; RNA; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107596,0.0004241696,0.0007581638,0.0001430449,0.0002540505,0.0005079297,0.0002595338,0.0003923212,0.001264805],"category_scores_gemma":[0.0006754288,0.0001554561,0.0005631703,0.0001316013,0.0002633565,0.0002240311,0.0001864207,0.0008809776,0.0002527922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006271513,"about_ca_system_score_gemma":0.000570806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001393112,"about_ca_topic_score_gemma":0.0024316,"domain_scores_codex":[0.9997165,0.0001247307,0.00001515422,0.00003793771,0.00003741692,0.00006827193],"domain_scores_gemma":[0.9995901,0.00007122156,0.00008191307,0.00004193977,0.00005235387,0.0001626194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3929593,0.03356741,0.204842,0.0004848266,0.001067084,0.0004784289,0.000849796,0.004147395,0.1682504,0.0002082131,0.004314319,0.1888307],"study_design_scores_gemma":[0.05055092,0.5042943,0.4060144,0.00006367944,0.0006505823,0.0008698151,0.0002304674,0.004050403,0.0284059,0.0002034996,0.004588942,0.00007705388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988576,0.0002924452,0.00008293298,0.00002660856,0.000006246807,0.000140163,0.000260591,0.00001179467,0.0003216023],"genre_scores_gemma":[0.998103,0.0001337425,0.0002978378,0.00007458212,0.00001255296,0.0001103044,0.0007326003,0.000007699126,0.0005275494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001393112,"threshold_uncertainty_score":0.005690277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02256180464424634,"score_gpt":0.290023477229044,"score_spread":0.2674616725847977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}